Among the 18% of adults who report having ever used GLP-1 drugs, the vast majority (84%) say they have been diagnosed with at least one of the predominant conditions these drugs are prescribed to treat, including obesity or being overweight in the past five years (77%), or ever being diagnosed with diabetes (49%) or heart disease (21%)
Grimelius L, Capella C, Buffa R, Polak JM, Pearse AG, and Solcia E
However, PlexusDx offers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan if your provider believes the dual-receptor approach outweighs reflux risk in your case
Emotional Eating Triggers Returning For many, GLP-1s helped take the emotional edge off food decisions by minimizing cravings and reducing reward-based eating
Scientists call anything that can bind to the receptor and cause the changes that create biological responses an agonist
A separate meta-analysis by Maisel and colleagues from 2017 reached similar conclusions, reinforcing naltrexones role as one of the best-studied medications for reducing alcohol consumption